- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04345263
Outcome of Full Pulpotomy Using Calcium Silicate Based Materials (pulpotomy)
September 15, 2021 updated by: Jordan University of Science and Technology
Outcome of Full Pulpotomy in Permanent Teeth With Carious Pulp Exposure, a Randomized Clinical Trial
Permanent teeth with carious pulp exposure and indicated for full pulpotomy will be treated using three different materials using aseptic technique and will be subsequently followed up clinically and radiographically at 6 months, 1 year and yearly up to 5 years.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
- The target sample size is 150 patients medically fit, having vital teeth with carious pulp exposure and complaining of pain.
- The patients tooth will receive full pulpotomy under aseptic conditions and it will be randomly assigned to one of 3 calcium silicate based materials namely, (Mineral trioxide Aggregate (MTA), Biodentine, and Bioceramic for capping the full pulpotomy followed by resin composite restoration.
- Follow up for pain levels will be done during the first week.
- clinical and radiographic examination will be done at 6 months, 1 year and yearly up to 5 years.
- Success of the procedure includes absence of clinical signs and symptoms, with absence of pathology in the root and periapex on periapical radiographs.
- The 3 materials will be compared in terms of clinical and radiographic outcomes.
- demographic data of the three groups will be also compared
- predictive factors of success will be also analyzed
- tooth color changes will be also measured using vita easy shade and will compared between the groups at 6 months and 1 year.
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
IRbid, Jordan, 21110
- Dental teaching centre Faculty Of Dentistry
-
Irbid, Jordan, 22110
- Jordan University of Science and Technology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 70 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Mature permanent tooth with carious lesion exposing the pulp,
- Positive response to cold test
- Clinical Diagnosis of reversible or irreversible pulpitis
- Restorable tooth by direct restoration or crown
- Healthy patient
Exclusion Criteria:
- Non vital teeth
- Teeth without pulp exposure
- Inability to achieve hemostasis within 10 min after pulpotomy
- Non restorable teeth or teeth that require post and core restoration
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: MTA pulpotomy
Tooth will receive MTA & resin composite restoration
|
Cutting the coronal portion of the pulp to the level of canal orifices and applying the dressing and restoration
Other Names:
|
Active Comparator: Biodentine pulpotomy
Tooth will receive Biodentine & resin composite restoration
|
Cutting the coronal portion of the pulp to the level of canal orifices and applying the dressing and restoration
Other Names:
|
Active Comparator: Bioceramic pulpotomy
Tooth will receive Bioceramic & resin composite restoration
|
Cutting the coronal portion of the pulp to the level of canal orifices and applying the dressing and restoration
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Degree of pain relief after treatment compared to preoperative pain level
Time Frame: 1 week
|
Absence of symptoms or significant pain reduction within the first week after treatment as measured on a numerical scale from 0 to 10 where zero means no pain and 10 is the most sever pain.
Visual analogue scale will be also used.
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Radiographic normalcy
Time Frame: 1 year and yearly up to 5 years
|
Absence of pathology in the root and the bone surrounding the apex
|
1 year and yearly up to 5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2017
Primary Completion (Actual)
May 2, 2018
Study Completion (Anticipated)
May 2, 2023
Study Registration Dates
First Submitted
April 9, 2020
First Submitted That Met QC Criteria
April 12, 2020
First Posted (Actual)
April 14, 2020
Study Record Updates
Last Update Posted (Actual)
September 22, 2021
Last Update Submitted That Met QC Criteria
September 15, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 503/2017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
Detailed participants data will be released within the publications resulting from the trial with reference to the registration number of the study.
If further details are required the principal investigator.
can be contacted via email.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carious Teeth
-
Assistance Publique - Hôpitaux de ParisUniversity Hospital, Clermont-Ferrand; Rennes University Hospital; Nantes University...UnknownInflammatory Pulp Diseases Related to Carious TeethFrance
-
Samara State Medical UniversityActive, not recruitingCarious and Non-carious Lesions of the TeethRussian Federation
-
Cairo UniversityUnknown
-
Al-Azhar UniversityRecruitingDental Wear | Carious ToothEgypt
-
Marmara UniversityNot yet recruiting
-
Mansoura UniversityActive, not recruiting
-
Cairo UniversityUnknown
-
Marmara UniversityNot yet recruiting
-
Minia UniversityCompleted
-
National Research Centre, EgyptActive, not recruiting
Clinical Trials on MTA pulpotomy
-
Cairo UniversityUnknownSymptomatic Irreversible Pulpitis
-
University GhentCompleted
-
Damascus UniversityCompleted
-
sherouk atef elsayedCairo UniversityNot yet recruiting
-
University of Maryland, BaltimoreActive, not recruitingPulpotomy | Vital Pulp Therapies | Indirect Pulp CapUnited States
-
Izmir Katip Celebi UniversityCompletedPrimary Teeth | Pulpotomy
-
Mansoura UniversityCompletedDecayed Primary MolarsEgypt
-
Cairo UniversityCompleted
-
Cairo UniversityUnknownPulp Disease, DentalEgypt